An evaluation of the GABA uptake blocker tiagabine in animal models of neuropathic and nociceptive pain

Drug Development Research

Volumn 44, Issue 2-3, 1998, Pages 106-113

  Giardina, William J ^a   Decker, Michael W ^a   Porsolt, Roger D ^b   Roux, Sylvain ^b   Collins, Stephen D ^a   Kim, David J B ^a   Bannon, Anthony W ^a  

^a ABBOTT LABORATORIES   (United States)

^b Phoenix International Pharmacology   (France)

Author keywords

Analgesia; Anticonvulsant; Hot plate; Tail flick

Indexed keywords

TIAGABINE;

4 AMINOBUTYRIC ACID UPTAKE; ALLODYNIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; DOSE RESPONSE; DRUG EFFECT; EDEMA; LATENT PERIOD; NEUROPATHY; NOCICEPTION; NONHUMAN; PERCEPTIVE THRESHOLD; RAT; TACTILE STIMULATION; TAIL FLICK TEST;

EID: 0031710115     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199806/07)44:2/3<106::AID-DDR8>3.0.CO;2-Q     Document Type: Article

References (35)

1. A receptors and excitatory amino acids in the mouse spinal cord. J Pharmacol Exp Ther 248:1034-1038.
2. Border LA, Murali Dhar TG, Smith KE, Weinshank RL, Branchek TA, Gluchowski C (1994): Tiagabine, SKF 89976A, CI-966 and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol 269:219-224.
3. Brasetrup C, Nielsen EB, Sonnewald U, Knutsen LJS, Andersen KE, Jansen JA, Andersen PH, Mortensen A, Frederiksen K (1990): (R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl] nipecotic acid binds with high affinity to the brain gamma-amino butyric acid uptake carrier. J Neurochem 54:639-647.
4. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994): Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55-63.
5. Collier HOJ, Dinneen LC, Johnson CA, Schneider C (1986): The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother 32:294-310.
6. Costa LG, Murphy SD (1984): Antinociceptive effect of the GABAmimetic 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP): Chronic treatment increases alpha-2 adrenoceptors in the mouse brain. J Pharmacol Exp Ther 229:386-390.
7. Dalby NO, Nielsen EB (1997): Comparison of the anticonvulsant profiles of tiagabine, lamotrigine. gabapentin and vigabatrin. Epilepsy Res 28:63-72.
8. D'Amour FE, Smith DL (1941): A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74-79.
9. Dixon WJ (1980): Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20:441-462.
10. Dubner R (1994): Methods of assessing pain in animals. In Wall PD, Melzack RD (eds): Textbook of Pain, 3rd ed. Edinburgh: Churchill Livingston, pp 293-302.
11. Eddy NB, Leimbach D (1953): Synthetic analgesics. II. Dithienylbutenyl and dithienylbutylamines. J Pharmacol Exp Ther 107:385-393.
12. Faingold CL, Randall ME, Copley CA (1990): Blockade of audiogenic seizures by a GABA-uptake inhibitor, NO-328, in the genetically epilepsy-prone rat. In Lubec G, Rosenthal GA (eds): Amino Acid: Chemistry, Biology and Medicine. Amsterdam: ESCOM Science Publishers B.V., pp 263-269.
13. Fink-Jensen A, Suzdak, PD, Swedberg, MD, Judge ME, Hansen L, Nielsen PG (1992): The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats. Eur J Pharmacol 220:197-201.
14. Gale K (1992): GABA and epilepsy: Basic concepts from preclinical research. Epilepsia 33:S3-S12.
15. Gustavson LE, Mengel HB (1995): Pharmacokinetics of tiagabine, a gamma-aminobutyric-acid-uptake inhibitor, in healthy subjects after single and multiple doses. Epilepsia 36:605-611.
16. Hammond DL, Washington JD (1993): Antagonism of L-baclofen-induced antinociception by CGP 35348 in the spinal cord of the rat. Eur J Pharmacol 234:255-262.
17. Ikegaki N, Saito N, Hashima M, Tanaka C (1994): Production of specific antibodies against GABA-transporter subtypes (GAT1, GAT2, GAT3) and their application to immunocytochemistry. Brain Res 26:47-54.
18. Judge ME, Swedberg MBD, Suzdak PD (1990): Tolerance to the cognitive impairing effects but not the anticonvulsant effects of NO-328, a selective GABA uptake inhibitor. Eur J Pharmacol 183:467.
19. Kim SH, Chung JM (1992): An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50:355-363.
20. Lipman AG (1996): Analgesic drugs for neuropathic and sympathetically maintained pain. Clin Geriatr Med 12:501-515.
21. Malcangio M, Bowery NG (1996): GABA and its receptors in the spinal cord. Trends Pharmaceut Sci 17:457-462.
22. A antagonist and nicotine-induced antinociception. Life Sci 61:221-225.
23. Nielsen EB, Suzdak PD, Andersen KE, Knutsen LJS, Sonnewald U, Braestrup C (1991): Characterization of tiagabine (NO-328), a new potent and selective CABA uptake inhibitor. Eur J Pharmacol 196:257-266.
24. Nishikawa T, Scatton B (1985): Inhibitory influence of GABA on central serotonergic transmission: Raphe nuclei as the neuroanatomical site of the GABAergic inhibition of cerebral serotonergic neurons. Brain Res 331:91-103.
25. Sachdeo RC, Leroy RF, Krauss GL, Drake ME, Green PM, Leppik IE, Shu VS, Ringham GL, Sommerville KW (1997): Tiagabine therapy for complex partial seizures. Arch Neurol 54:595-601.
26. Sawynok J (1987): Gabaergic mechanisms of analgesia: An update. Pharmacol Biochem Behav 26:463-474.
27. Sheardown JU, Weis LJ, Knutsen M, Swedberg M, Suzdak PD (1989): Analgesic effect of the GABA uptake inhibitor NO-328 (N-(4,4-di(3-methyl-2-thienyl)but-3-en-1-yl)nipecotic acid). Soc Neurosci 15:602.
28. Stacy BR (1996): Effective management of chronic pain. Postgrad Med 100:281-296.
29. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K (1992): The formalin test: An evaluation of the method. Pain 51:5-17.
30. Uthman BM, Rowan J, Ahmann PA, Leppik IE, Schachter SC, Sommerville KW, Shu V (1998): Tiagabine for complex partical seizures. Arch Neurol 55:56-62.
31. Vanght JL, Pelley K, Costa LG, Setler P, Enna SJ (1985): A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and Bacolfen. Neuropharmacology 24:211-216.
32. Wheeler-Aceto H, Cowan A (1991): Standardization of the rat formalin test for the evaluation of analgesic. Psychopharmacology 104:35-44.
33. Winter CA, Risley GA, Nuss GW (1962): Carrageenan-induced edema in the hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111:544-547.
34. Woolf CJ (1983): Evidnce for a central component of post-injury pain hypersensitivity. Nature 306:686-688.
35. Zorn SN, Enna SJ (1985): GABA uptake inhibitors produce a greater antinociceptive response in the mouse tail-immersion assay than other types of GABAergic drugs. Life Sci 37:1901-1912.